In this study, we demonstrate for the first time that berberine sensitizes malignant glioma cells for As2O3-mediated suppression of migration and invasiveness likely via decreased PKC signaling and MMP-2 activation in the extracellular matrix. Here, PRRT2 is linked to glioma.